Gujarat Inject (Kerala) share news, announcements and annual reports
BSE: 524238Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹11.22.
30 Oct: open ₹11.29, high ₹11.54, low ₹10.77
- Next results date: the board meets on 5 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹163 Cr2,790th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 54.64
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 13.82
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 27.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 32.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,44,603
Gujarat Inject (Kerala) share news and announcements
407 announcements, routine notices left out, newest first. Page 3 of 9.
Aug 2024
2 Aug · Board meeting
Meeting on 10 Aug 2024: quarterly results
Jul 2024
4 Jul · Intimation Informing The Approval Of Application For Reclassification From 'PROMOTER' Category To 'PUBLIC' Category
Jun 2024
10 Jun · Board meeting
Meeting on 10 Jun 202410 Jun · Management
10 Jun · Management
May 2024
27 May · Announcement under Regulation 30 (LODR)-Change in Registered Office Address
17 May · Disclosure Under Regulation 30 Read With Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Submission Of Application For Re-Classification From 'Promoter' Category To 'Public' Category
15 May · Board meeting
Meeting on 15 May 202413 May · Intimation Of Receipt Of Request For Reclassification From PROMOTER' Category To 'PUBLIC' Category
3 May · Board meeting
Meeting on 3 May 20242 May · Board meeting
Meeting on 9 May 2024: audited results
Apr 2024
27 Apr · Certificate Of Practicing Company Secretary Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
17 Apr · The Compliance Certificate In Pursuance Of Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
10 Apr · Announcement under Regulation 30 (LODR)-Allotment
6 Apr · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
3 Apr · Announcement under Regulation 30 (LODR)-Allotment
Mar 2024
23 Mar · Announcement under Regulation 30 (LODR)-Allotment
21 Mar · Announcement under Regulation 30 (LODR)-Allotment
16 Mar · Announcement under Regulation 30 (LODR)-Allotment
Feb 2024
8 Feb · Announcement under Regulation 30 (LODR)-Allotment
5 Feb · Board meeting
Meeting on 13 Feb 2024: quarterly results
Jan 2024
20 Jan · Meeting
Dec 2023
16 Dec · Announcement under Regulation 30 (LODR)-Issue of Securities
13 Dec · Board meeting
Meeting on 16 Dec 2023: preferential issue of shares
Nov 2023
17 Nov · Board meeting
Meeting on 22 Nov 20233 Nov · Board meeting
Meeting on 6 Nov 2023: quarterly results